{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:31:29Z","timestamp":1793035889243,"version":"4.5.0"},"reference-count":107,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2024,11,4]]},"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study aimed to investigate how diosmetin interacts with seven target receptors\nassociated with oxidative stress (OS) and validate its antioxidant properties for the potential\nmanagement of Parkinson\u2019s disease (PD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In PD, the degeneration of dopaminergic cells is strongly influenced by OS. This\nstressor is intricately connected to various mechanisms involved in neurodegeneration, such as mitochondrial\ndysfunction, neuroinflammation, and excitotoxicity induced by nitric oxide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The aim of this research was to establish a molecular connection between diosmetin\nand OS-associated target receptors was the goal, and it investigated how this interaction can lessen\nPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Seven molecular targets - Adenosine A2A (AA2A), Peroxisome Proliferator-Activated\nReceptor Gamma (PPAR\u03b3), Protein Kinase AKT1, Nucleolar Receptor NURR1, Liver - X Receptor\nBeta (LXR\u03b2), Monoamine Oxidase - B (MAO-B) and Tropomyosin receptor kinase B (TrkB)\nwere obtained from RCSB. Molecular docking software was employed to determine molecular interactions,\nwhile antioxidant activity was assessed through in-vitro assays against various free radicals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Diosmetin exhibited interactions with all seven target receptors at their binding sites.\nNotably, it showed superior interaction with AA2A and NURR1 compared to native ligands, with\nbinding energies of -7.55, and -6.34 kcal\/mol, respectively. Additionally, significant interactions\nwere observed with PPAR\u03b3, AKT1, LXR\u03b2, MAO-B, and TrkB with binding energies of -8.34,\n-5.42, -7.66, -8.82, -8.45 kcal\/mol, respectively. Diosmetin also demonstrated antioxidant activity\nagainst various free radicals, particularly against hypochlorous acid (HOCl) and nitric oxide (NO)\nfree radicals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Diosmetin possibly acts on several target receptors linked to the pathophysiology of\nPD, demonstrating promise as an OS inhibitor and scavenger.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298665333333240909104354","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T03:11:03Z","timestamp":1727320263000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Investigating In silico and In vitro Therapeutic Potential of Diosmetin as the Anti-Parkinson Agent"],"prefix":"10.2174","volume":"31","author":[{"given":"Krishna Kumar","family":"Varshney","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeetendra Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Chitkara School of Pharmacy,\nChitkara University, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"Hayes M.T.","year":"2019","unstructured":"Hayes M.T.; Parkinson\u2019s disease and Parkinsonism. Am J Med  2019,132(7),802-807","journal-title":"Am J Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","volume":"103","author":"Reich S.G.","year":"2019","unstructured":"Reich S.G.; Savitt J.M.; Parkinson\u2019s disease. Med Clin North Am  2019,103(2),337-350","journal-title":"Med Clin North Am"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1179\/016164105X22057","volume":"27","author":"Allam M.F.","year":"2005","unstructured":"Allam M.F.; Del Castillo A.S.; Navajas R.F.C.; Parkinson\u2019s disease risk factors: Genetic, environmental, or both? Neurol Res  2005,27(2),206-208","journal-title":"Neurol Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"Armstrong M.J.","year":"2020","unstructured":"Armstrong M.J.; Okun M.S.; Diagnosis and treatment of Parkinson disease. JAMA  2020,323(6),548-560","journal-title":"JAMA"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"110776","DOI":"10.1016\/j.biopha.2020.110776","volume":"131","author":"Khatri D.K.","year":"2020","unstructured":"Khatri D.K.; Choudhary M.; Sood A.; Singh S.B.; Anxiety: An ignored aspect of Parkinson\u2019s disease lacking attention. Biomed Pharmacother  2020,131,110776","journal-title":"Biomed Pharmacother"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.4103\/0028-3886.266268","volume":"67","author":"Malek N.","year":"2019","unstructured":"Malek N.; Deep brain stimulation in Parkinson\u2019s Disease. Neurol India  2019,67(4),968-978","journal-title":"Neurol India"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/826046","volume":"2013","author":"Streck E.L.","year":"2013","unstructured":"Streck E.L.; Czapski G.A.; Gon\u00e7alves da Silva C.; Neurodegeneration, mitochondrial dysfunction, and oxidative stress. Oxid Med Cell Longev  2013,2013,1-2","journal-title":"Oxid Med Cell Longev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2017.04.018","volume":"133","author":"Zhang J.","year":"2017","unstructured":"Zhang J.; Butterfield D.A.; Oxidative stress and neurodegeneration. Brain Res Bull  2017,133,1-3","journal-title":"Brain Res Bull"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.parkreldis.2020.09.025","volume":"80","author":"Mori A.","year":"2020","unstructured":"Mori A.; How do adenosine A receptors regulate motor function? Parkinsonism Relat Disord  2020,80(Suppl. 1),S13-S20","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.parkreldis.2020.09.027","volume":"80","author":"Fredholm B.B.","year":"2020","unstructured":"Fredholm B.B.; Svenningsson P.; Why target brain adenosine receptors? A historical perspective. Parkinsonism Relat Disord  2020,80(Suppl. 1),S3-S6","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1212\/01.WNL.0000095211.71092.A0","volume":"61","author":"Mori A.","year":"2003","unstructured":"Mori A.; Shindou T.; Modulation of GABAergic transmission in the striatopallidal system by adenosine A  receptors. Neurology  2003,61(11_suppl_6)(Suppl. 6),S44-S48","journal-title":"Neurology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11302-008-9100-8","volume":"4","author":"Cie\u015blak M.","year":"2008","unstructured":"Cie\u015blak M.; Komoszy\u0144ski M.; Wojtczak A.; Adenosine A2A receptors in Parkinson\u2019s disease treatment. Purinergic Signal  2008,4(4),305-312","journal-title":"Purinergic Signal"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.3390\/molecules27072366","volume":"27","author":"Mori A.","year":"2022","unstructured":"Mori A.; Chen J.F.; Uchida S.; Durlach C.; King S.M.; Jenner P.; The pharmacological potential of adenosine A receptor antagonists for treating Parkinson\u2019s disease. Molecules  2022,27(7),2366","journal-title":"Molecules"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2174\/1389450111314070004","volume":"14","author":"Carta A.R.","year":"2013","unstructured":"Carta A.R.; PPAR-\u03b3: therapeutic prospects in Parkinson\u2019s disease. Curr Drug Targets  2013,14(7),743-751","journal-title":"Curr Drug Targets"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12035-012-8259-8","volume":"46","author":"Chen Y.C.","year":"2012","unstructured":"Chen Y.C.; Wu J.S.; Tsai H.D.; Huang C.Y.; Chen J.J.; Sun G.Y.; Lin T.N.; Peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) and neurodegenerative disorders. Mol Neurobiol  2012,46(1),114-124","journal-title":"Mol Neurobiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.3390\/ijms23084148","volume":"23","author":"Liu T.W.","year":"2022","unstructured":"Liu T.W.; Chen C.M.; Chang K.H.; Biomarker of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci  2022,23(8),4148","journal-title":"Int J Mol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neulet.2011.06.038","volume":"501","author":"Ran C.","year":"2011","unstructured":"Ran C.; Westerlund M.; Anvret A.; Willows T.; Sydow O.; Galter D.; Belin A.C.; Genetic studies of the protein kinase AKT1 in Parkinson\u2019s disease. Neurosci Lett  2011,501(1),41-44","journal-title":"Neurosci Lett"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neulet.2008.03.026","volume":"436","author":"Xiromerisiou G.","year":"2008","unstructured":"Xiromerisiou G.; Hadjigeorgiou G.M.; Papadimitriou A.; Katsarogiannis E.; Gourbali V.; Singleton A.B.; Association between AKT1 gene and Parkinson\u2019s disease: A protective haplotype. Neurosci Lett  2008,436(2),232-234","journal-title":"Neurosci Lett"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/j.yexmp.2022.104846","volume":"129","author":"Goyal A.","year":"2023","unstructured":"Goyal A.; Agrawal A.; Verma A.; Dubey N.; The PI3K-AKT pathway: A plausible therapeutic target in Parkinson\u2019s disease. Exp Mol Pathol  2023,129,104846","journal-title":"Exp Mol Pathol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-022-00544-w","volume":"17","author":"Al-Nusaif M.","year":"2022","unstructured":"Al-Nusaif M.; Yang Y.; Li S.; Cheng C.; Le W.; The role of NURR1 in metabolic abnormalities of Parkinson\u2019s disease. Mol Neurodegener  2022,17(1),46","journal-title":"Mol Neurodegener"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"16184","DOI":"10.3390\/ijms232416184","volume":"23","author":"Al-Nusaif M.","year":"2022","unstructured":"Al-Nusaif M.; Lin Y.; Li T.; Cheng C.; Le W.; Advances in NURR1-regulated neuroinflammation associated with Parkinson\u2019s disease. Int J Mol Sci  2022,23(24),16184","journal-title":"Int J Mol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/cne.20828","volume":"494","author":"Chu Y.","year":"2006","unstructured":"Chu Y.; Le W.; Kompoliti K.; Jankovic J.; Mufson E.J.; Kordower J.H.; Nurr1 in Parkinson\u2019s disease and related disorders. J Comp Neurol  2006,494(3),495-514","journal-title":"J Comp Neurol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneurol.2013.209","volume":"9","author":"Decressac M.","year":"2013","unstructured":"Decressac M.; Volakakis N.; Bj\u00f6rklund A.; Perlmann T.; NURR1 in Parkinson disease\u2014from pathogenesis to therapeutic potential. Nat Rev Neurol  2013,9(11),629-636","journal-title":"Nat Rev Neurol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.chembiol.2019.02.002","volume":"26","author":"Bruning J.M.","year":"2019","unstructured":"Bruning J.M.; Wang Y.; Oltrabella F.; Tian B.; Kholodar S.A.; Liu H.; Bhattacharya P.; Guo S.; Holton J.M.; Fletterick R.J.; Jacobson M.P.; England P.M.; Covalent modification and regulation of the nuclear receptor Nurr1 by a dopamine metabolite. Cell Chem Biol  2019,26(5),674-685.e6","journal-title":"Cell Chem Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12035-023-03561-y","volume":"61","author":"Alnaaim S.A.","year":"2024","unstructured":"Alnaaim S.A.; Al-Kuraishy H.M.; Alexiou A.; Papadakis M.; Saad H.M.; Batiha G.E.S.; Role of brain liver X receptor in Parkinson\u2019s disease: Hidden treasure and emerging opportunities. Mol Neurobiol  2024,61(1),341-357","journal-title":"Mol Neurobiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1038\/s41598-018-20980-3","volume":"8","author":"Hichor M.","year":"2018","unstructured":"Hichor M.; Sundaram V.K.; Eid S.A.; Abdel-Rassoul R.; Petit P.X.; Borderie D.; Bastin J.; Eid A.A.; Manuel M.; Grenier J.; Massaad C.; Liver X.; Liver X Receptor exerts a protective effect against the oxidative stress in the peripheral nerve. Sci Rep  2018,8(1),2524","journal-title":"Sci Rep"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nchembio.1156","volume":"9","author":"Theofilopoulos S.","year":"2013","unstructured":"Theofilopoulos S.; Wang Y.; Kitambi S.S.; Sacchetti P.; Sousa K.M.; Bodin K.; Kirk J.; Salt\u00f3 C.; Gustafsson M.; Toledo E.M.; Karu K.; Gustafsson J.\u00c5.; Steffensen K.R.; Ernfors P.; Sj\u00f6vall J.; Griffiths W.J.; Arenas E.; Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis. Nat Chem Biol  2013,9(2),126-133","journal-title":"Nat Chem Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e0174470","DOI":"10.1371\/journal.pone.0174470","volume":"12","author":"Paterniti I.","year":"2017","unstructured":"Paterniti I.; Campolo M.; Siracusa R.; Cordaro M.; Di Paola R.; Calabrese V.; Navarra M.; Cuzzocrea S.; Esposito E.; Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson\u2019s disease. PLoS One  2017,12(4),e0174470","journal-title":"PLoS One"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JPD-212976","volume":"12","author":"Tan Y.Y.","year":"2022","unstructured":"Tan Y.Y.; Jenner P.; Chen S.D.; Monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: Past, present, and future. J Parkinsons Dis  2022,12(2),477-493","journal-title":"J Parkinsons Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00702-023-02623-8","volume":"130","author":"Regensburger M.","year":"2023","unstructured":"Regensburger M.; Ip C.W.; Kohl Z.; Schrader C.; Urban P.P.; Kassubek J.; Jost W.H.; Clinical benefit of MAO-B and COMT inhibition in Parkinson\u2019s disease: practical considerations. J Neural Transm (Vienna)  2023,130(6),847-861","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2174\/1570159X15666171128145423","volume":"16","author":"Ishiki H.M.","year":"2018","unstructured":"Ishiki H.M.; Filho J.M.B.; da Silva M.S.; Scotti M.T.; Scotti L.; Computer-aided drug design applied to Parkinson targets. Curr Neuropharmacol  2018,16(6),865-880","journal-title":"Curr Neuropharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.4103\/1673-5374.306066","volume":"16","author":"Singh M.P.","year":"2021","unstructured":"Singh M.P.; Singh B.; Rai S.N.; Singh P.; Varshney R.; Chaturvedi V.K.; Vamanu E.; Promising drug targets and associated therapeutic interventions in Parkinson\u2019s disease. Neural Regen Res  2021,16(9),1730-1739","journal-title":"Neural Regen Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.3390\/molecules27092834","volume":"27","author":"Gnanaraj C.","year":"2022","unstructured":"Gnanaraj C.; Sekar M.; Fuloria S.; Swain S.S.; Gan S.H.; Chidambaram K.; Rani N.N.I.M.; Balan T.; Stephenie S.; Lum P.T.; Jeyabalan S.; Begum M.Y.; Chandramohan V.; Thangavelu L.; Subramaniyan V.; Fuloria N.K.; In silico molecular docking analysis of Karanjin against Alzheimer\u2019s and Parkinson\u2019s diseases as a potential natural lead molecule for new drug design, development and therapy. Molecules  2022,27(9),2834","journal-title":"Molecules"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"107046","DOI":"10.1016\/j.intimp.2020.107046","volume":"89","author":"Lee D.H.","year":"2020","unstructured":"Lee D.H.; Park J.K.; Choi J.; Jang H.; Seol J.W.; Anti-inflammatory effects of natural flavonoid diosmetin in IL-4 and LPS-induced macrophage activation and atopic dermatitis model. Int Immunopharmacol  2020,89,107046","journal-title":"Int Immunopharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12032-023-02180-w","volume":"40","author":"Pan Z.","year":"2023","unstructured":"Pan Z.; Tan Z.; Li H.; Wang Y.; Du H.; Sun J.; Li C.; Ye S.; Li X.; Quan J.; Diosmetin induces apoptosis and protective autophagy in human gastric cancer HGC-27 cells via the PI3K\/Akt\/FoxO1 and MAPK\/JNK pathways. Med Oncol  2023,40(11),319","journal-title":"Med Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/tox.23504","volume":"37","author":"Shi M.","year":"2022","unstructured":"Shi M.; Wang J.; Bi F.; Bai Z.; Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2\/  signaling pathway activation and  inflammasome inhibition. Environ Toxicol  2022,37(6),1529-1542","journal-title":"Environ Toxicol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.3390\/cimb45060297","volume":"45","author":"Ahmad T.","year":"2023","unstructured":"Ahmad T.; Khan T.; Kirabo A.; Shah A.J.; Antioxidant flavonoid diosmetin is cardioprotective in a rat model of myocardial infarction induced by beta 1-adrenergic receptors activation. Curr Issues Mol Biol  2023,45(6),4675-4686","journal-title":"Curr Issues Mol Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"7331","DOI":"10.3892\/mmr.2018.8750","volume":"17","author":"Wang C.","year":"2018","unstructured":"Wang C.; Liao Y.; Wang S.; Wang D.; Wu N.; Xu Q.; Jiang W.; Qiu M.; Liu C.; Cytoprotective effects of diosmetin against hydrogen peroxide-induced L02 cell oxidative damage via activation of the Nrf2-ARE signaling pathway. Mol Med Rep  2018,17(5),7331-7338","journal-title":"Mol Med Rep"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3892\/mmr.2020.11241","volume":"22","author":"Si Q.","year":"2020","unstructured":"Si Q.; Shi Y.; Huang D.; Zhang N.; Diosmetin alleviates hypoxia-induced myocardial apoptosis by inducing autophagy through AMPK activation. Mol Med Rep  2020,22(2),1335-1341","journal-title":"Mol Med Rep"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"10026","DOI":"10.3390\/ijms221810026","volume":"22","author":"Bednarska K.","year":"2021","unstructured":"Bednarska K.; Fecka I.; Potential of vasoprotectives to inhibit non-enzymatic protein glycation, and reactive carbonyl and oxygen species uptake. Int J Mol Sci  2021,22(18),10026","journal-title":"Int J Mol Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.bjp.0707305","volume":"152","author":"Ekins S.","year":"2007","unstructured":"Ekins S.; Mestres J.; Testa B.; In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol  2007,152(1),9-20","journal-title":"Br J Pharmacol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/0975-1483.100027","volume":"4","author":"Azam F.","year":"2012","unstructured":"Azam F.; Madi A.M.; Ali H.I.; Molecular docking and prediction of pharmacokinetic properties of dual mechanism drugs that block MAO-B and adenosine A2A receptors for the treatment of Parkinson\u2019s disease. J Young Pharm  2012,4(3),184-192","journal-title":"J Young Pharm"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"133354","DOI":"10.1016\/j.molstruc.2022.133354","volume":"1265","author":"Kumar A.P.","year":"2022","unstructured":"Kumar A.P.; Mandal S.; P P.; Faizan S.; Kumar B.R.P.; Dhanabal S.P.; Justin A.; Rational design, molecular docking, dynamic simulation, synthesis, PPAR-\u03b3 competitive binding and transcription analysis of novel glitazones. J Mol Struct  2022,1265,133354","journal-title":"J Mol Struct"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/1752570","volume":"2021","author":"Liu Y.","year":"2021","unstructured":"Liu Y.; Yu L.; Zhang J.; Xie D.; Zhang X.; Yu J.; Network pharmacology-based and molecular docking-based analysis of suanzaoren decoction for the treatment of Parkinson\u2019s disease with sleep disorder. BioMed Res Int  2021,2021,1-12","journal-title":"BioMed Res Int"},{"key":"ref=45","first-page":"596","volume":"15","author":"Ni P.","year":"2023","unstructured":"Ni P.; Zhao B.; Pang Y.; Pan K.; Mechanism of tianma gouteng decoction in the treatment of Parkinson\u2019s disease based on network pharmacology and molecular docking. Am J Transl Res  2023,15(1),596-611","journal-title":"Am J Transl Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/molecules22010088","volume":"22","author":"Komati R.","year":"2017","unstructured":"Komati R.; Spadoni D.; Zheng S.; Sridhar J.; Riley K.; Wang G.; Ligands of therapeutic utility for the liver X receptors. Molecules  2017,22(1),88","journal-title":"Molecules"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1021\/acs.jmedchem.8b00204","volume":"61","author":"Jaiteh M.","year":"2018","unstructured":"Jaiteh M.; Zeifman A.; Saarinen M.; Svenningsson P.; Br\u00e9a J.; Loza M.I.; Carlsson J.; Docking screens for dual inhibitors of disparate drug targets for Parkinson\u2019s disease. J Med Chem  2018,61(12),5269-5278","journal-title":"J Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"20210027","DOI":"10.1515\/jib-2021-0027","volume":"19","author":"Boulaamane Y.","year":"2022","unstructured":"Boulaamane Y.; Ibrahim M.A.A.; Britel M.R.; Maurady A.; In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors\/AA  R antagonists for the treatment of Parkinson\u2019s disease. J Integr Bioinform  2022,19(4),20210027","journal-title":"J Integr Bioinform"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jcc.20222","volume":"26","author":"Cho A.E.","year":"2005","unstructured":"Cho A.E.; Guallar V.; Berne B.J.; Friesner R.; Importance of accurate charges in molecular docking: Quantum mechanical\/molecular mechanical (QM\/MM) approach. J Comput Chem  2005,26(9),915-931","journal-title":"J Comput Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1021\/ci300417y","volume":"53","author":"Hou X.","year":"2013","unstructured":"Hou X.; Du J.; Zhang J.; Du L.; Fang H.; Li M.; How to improve docking accuracy of AutoDock4.2: a case study using different electrostatic potentials. J Chem Inf Model  2013,53(1),188-200","journal-title":"J Chem Inf Model"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e1004586","DOI":"10.1371\/journal.pcbi.1004586","volume":"11","author":"Ravindranath P.A.","year":"2015","unstructured":"Ravindranath P.A.; Forli S.; Goodsell D.S.; Olson A.J.; Sanner M.F.; AutoDockFR: Advances in protein-ligand docking with explicitly specified binding site flexibility. PLOS Comput Biol  2015,11(12),e1004586","journal-title":"PLOS Comput Biol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1472-6807-13-S1-S11","volume":"13","author":"Dhanik A.","year":"2013","unstructured":"Dhanik A.; McMurray J.S.; Kavraki L.E.; DINC: a new AutoDock-based protocol for docking large ligands. BMC Struct Biol  2013,13,S11","journal-title":"BMC Struct Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; Sanner M.F.; Belew R.K.; Goodsell D.S.; Olson A.J.; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem  2009,30(16),2785-2791","journal-title":"J Comput Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"Forli S.","year":"2016","unstructured":"Forli S.; Huey R.; Pique M.E.; Sanner M.F.; Goodsell D.S.; Olson A.J.; Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc  2016,11(5),905-919","journal-title":"Nat Protoc"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.22270\/jddt.v8i4.1736","volume":"8","author":"Dev S.K.","year":"2018","unstructured":"Dev S.K.; Choudhury P.K.; Srivastava R.; Sharma M.; Phytochemical characterization and antioxidant assessment of herbal extracts. J Drug Deliv Ther  2018,8(4),126-133","journal-title":"J Drug Deliv Ther"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.phrp.2013.09.003","volume":"4","author":"Jan S.","year":"2013","unstructured":"Jan S.; Khan M.R.; Rashid U.; Bokhari J.; Assessment of antioxidant potential, total phenolics and flavonoids of different solvent fractions of monotheca buxifolia fruit. Osong Public Health Res Perspect  2013,4(5),246-254","journal-title":"Osong Public Health Res Perspect"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/molecules27041326","volume":"27","author":"Baliyan S.","year":"2022","unstructured":"Baliyan S.; Mukherjee R.; Priyadarshini A.; Vibhuti A.; Gupta A.; Pandey R.P.; Chang C.M.; Determination of antioxidants by DPPH radical scavenging activity and quantitative phytochemical analysis of Ficus religiosa. Molecules  2022,27(4),1326","journal-title":"Molecules"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","volume":"299","author":"Benzie I.F.F.","year":"1999","unstructured":"Benzie I.F.F.; Strain J.J.; Ferric reducing\/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol  1999,299,15-27","journal-title":"Methods Enzymol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/0250-474X.91574","volume":"73","author":"Rajurkar N.","year":"2011","unstructured":"Rajurkar N.; Hande S.M.; Estimation of phytochemical content and antioxidant activity of some selected traditional Indian medicinal plants. Indian J Pharm Sci  2011,73(2),146-151","journal-title":"Indian J Pharm Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/0973-1296.62889","volume":"6","author":"Zheleva-Dimitrova D.","year":"2010","unstructured":"Zheleva-Dimitrova D.; Nedialkov P.; Kitanov G.; Radical scavenging and antioxidant activities of methanolic extracts from Hypericum species growing in Bulgaria. Pharmacogn Mag  2010,6(22),74-78","journal-title":"Pharmacogn Mag"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1021\/jf9913458","volume":"48","author":"Pulido R.","year":"2000","unstructured":"Pulido R.; Bravo L.; Saura-Calixto F.; Antioxidant activity of dietary polyphenols as determined by a modified ferric reducing\/antioxidant power assay. J Agric Food Chem  2000,48(8),3396-3402","journal-title":"J Agric Food Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s13197-015-1994-x","volume":"53","author":"Fernandes R.P.P.","year":"2016","unstructured":"Fernandes R.P.P.; Trindade M.A.; Tonin F.G.; Lima C.G.; Pugine S.M.P.; Munekata P.E.S.; Lorenzo J.M.; de Melo M.P.; Evaluation of antioxidant capacity of 13 plant extracts by three different methods: cluster analyses applied for selection of the natural extracts with higher antioxidant capacity to replace synthetic antioxidant in lamb burgers. J Food Sci Technol  2016,53(1),451-460","journal-title":"J Food Sci Technol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5268584","volume":"2021","author":"Priyanthi C.","year":"2021","unstructured":"Priyanthi C.; Sivakanesan R.; The total antioxidant capacity and the total phenolic content of rice using water as a solvent. Int J Food Sci  2021,2021,1-6","journal-title":"Int J Food Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1472-6882-8-63","volume":"8","author":"Hazra B.","year":"2008","unstructured":"Hazra B.; Biswas S.; Mandal N.; Antioxidant and free radical scavenging activity of Spondias pinnata. BMC Complement Altern Med  2008,8(1),63","journal-title":"BMC Complement Altern Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1080\/10942912.2011.587382","volume":"16","author":"Roy S.","year":"2013","unstructured":"Roy S.; Hazra B.; Mandal N.; Chaudhuri T.K.; Assessment of the antioxidant and free radical scavenging activities of methanolic extract of Diplazium esculentum. Int J Food Prop  2013,16(6),1351-1370","journal-title":"Int J Food Prop"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.toxrep.2021.10.011","volume":"8","author":"Akamo A.J.","year":"2021","unstructured":"Akamo A.J.; Akinloye D.I.; Ugbaja R.N.; Adeleye O.O.; Dosumu O.A.; Eteng O.E.; Antiya M.C.; Amah G.; Ajayi O.A.; Faseun S.O.; Naringin prevents cyclophosphamide-induced erythrocytotoxicity in rats by abrogating oxidative stress. Toxicol Rep  2021,8,1803-1813","journal-title":"Toxicol Rep"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fphar.2015.00277","volume":"6","author":"Sarwar R.","year":"2015","unstructured":"Sarwar R.; Farooq U.; Khan A.; Naz S.; Khan S.; Khan A.; Rauf A.; Bahadar H.; Uddin R.; Evaluation of antioxidant, free radical scavenging, and antimicrobial activity of quercus incana roxb. Front Pharmacol  2015,6,277","journal-title":"Front Pharmacol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0076-6879(94)33026-3","volume":"233","author":"Beckman J.S.","year":"1994","unstructured":"Beckman J.S.; Chen J.; Ischiropoulos H.; Crow J.P.; Oxidative chemistry of peroxynitrite. Methods Enzymol  1994,233,229-240","journal-title":"Methods Enzymol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0014-5793(00)02234-1","volume":"486","author":"Bailly F.","year":"2000","unstructured":"Bailly F.; Zoete V.; Vamecq J.; Catteau J.P.; Bernier J.L.; Antioxidant actions of ovothiol-derived 4-mercaptoimidazoles: glutathione peroxidase activity and protection against peroxynitrite-induced damage. FEBS Lett  2000,486(1),19-22","journal-title":"FEBS Lett"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"6006","DOI":"10.1021\/bi00524a013","volume":"20","author":"Klein S.M.","year":"1981","unstructured":"Klein S.M.; Cohen G.; Cederbaum A.I.; Production of formaldehyde during metabolism of dimethyl sulfoxide by hydroxyl radical-generating systems. Biochemistry  1981,20(21),6006-6012","journal-title":"Biochemistry"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s13197-011-0389-x","volume":"50","author":"Loganayaki N.","year":"2013","unstructured":"Loganayaki N.; Siddhuraju P.; Manian S.; Antioxidant activity and free radical scavenging capacity of phenolic extracts from Helicteres isora L. and Ceiba pentandra L. J Food Sci Technol  2013,50(4),687-695","journal-title":"J Food Sci Technol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1042\/bj2480973","volume":"248","author":"Aruoma O.I.","year":"1987","unstructured":"Aruoma O.I.; Halliwell B.; Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. Biochem J  1987,248(3),973-976","journal-title":"Biochem J"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"173768","DOI":"10.1093\/ecam\/nep072","volume":"2011","author":"Mandal S.","year":"2011","unstructured":"Mandal S.; Hazra B.; Sarkar R.; Biswas S.; Mandal N.; Assessment of the antioxidant and reactive oxygen species scavenging activity of methanolic extract of Caesalpinia crista leaf. Evid Based Complement Alternat Med  2011,2011(1),173768","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"Agu P.C.","year":"2023","unstructured":"Agu P.C.; Afiukwa C.A.; Orji O.U.; Ezeh E.M.; Ofoke I.H.; Ogbu C.O.; Ugwuja E.I.; Aja P.M.; Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep  2023,13(1),13398","journal-title":"Sci Rep"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"217","DOI":"10.6026\/973206300200217","volume":"20","author":"Grewal A.","year":"2024","unstructured":"Grewal A.; Sheokand D.; Saini V.; Kumar A.; Molecular docking analysis of \u03b1-Synuclein aggregation with Anle138b. Bioinformation  2024,20(3),217-222","journal-title":"Bioinformation"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12896-021-00697-4","volume":"21","author":"Yahaya M.A.F.","year":"2021","unstructured":"Yahaya M.A.F.; Bakar A.R.A.; Stanslas J.; Nordin N.; Zainol M.; Mehat M.Z.; Insights from molecular docking and molecular dynamics on the potential of vitexin as an antagonist candidate against lipopolysaccharide (LPS) for microglial activation in neuroinflammation. BMC Biotechnol  2021,21(1),38","journal-title":"BMC Biotechnol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.2147\/IJN.S93918","volume":"10","author":"Ganesan P.","year":"2015","unstructured":"Ganesan P.; Ko H.M.; Kim I.S.; Choi D.K.; Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson\u2019s disease models. Int J Nanomedicine  2015,10,6757-6772","journal-title":"Int J Nanomedicine"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3390\/antiox10121859","volume":"10","author":"Thiruvengadam M.","year":"2021","unstructured":"Thiruvengadam M.; Venkidasamy B.; Subramanian U.; Samynathan R.; Ali Shariati M.; Rebezov M.; Girish S.; Thangavel S.; Dhanapal A.R.; Fedoseeva N.; Lee J.; Chung I.M.; Bioactive compounds in oxidative stress-mediated diseases: Targeting the NRF2\/ARE signaling pathway and epigenetic regulation. Antioxidants  2021,10(12),1859","journal-title":"Antioxidants"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/wsbm.52","volume":"2","author":"Hughey J.J.","year":"2010","unstructured":"Hughey J.J.; Lee T.K.; Covert M.W.; Computational modeling of mammalian signaling networks. Wiley Interdiscip Rev Syst Biol Med  2010,2(2),194-209","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/glia.23579","volume":"67","author":"Aires I.D.","year":"2019","unstructured":"Aires I.D.; Boia R.; Rodrigues-Neves A.C.; Madeira M.H.; Marques C.; Ambr\u00f3sio A.F.; Santiago A.R.; Blockade of microglial adenosine A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells. Glia  2019,67(5),896-914","journal-title":"Glia"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s40263-014-0161-7","volume":"28","author":"Pinna A.","year":"2014","unstructured":"Pinna A.; Adenosine A2A receptor antagonists in Parkinson\u2019s disease: Progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued. CNS Drugs  2014,28(5),455-474","journal-title":"CNS Drugs"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1021\/cn2000537","volume":"2","author":"Shook B.C.","year":"2011","unstructured":"Shook B.C.; Jackson P.F.; Adenosine A receptor antagonists and Parkinson\u2019s disease. ACS Chem Neurosci  2011,2(10),555-567","journal-title":"ACS Chem Neurosci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ebiom.2016.06.017","volume":"9","author":"Feng X.","year":"2016","unstructured":"Feng X.; Weng D.; Zhou F.; Owen Y.D.; Qin H.; Zhao J.; WenYu ; Huang Y.; Chen J.; Fu H.; Yang N.; Chen D.; Li J.; Tan R.; Shen P.; Activation of PPAR\u03b3 by a natural flavonoid modulator, apigenin ameliorates obesity-related inflammation via regulation of macrophage polarization. EBioMedicine  2016,9,61-76","journal-title":"EBioMedicine"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/chemistry3020045","volume":"3","author":"Hasegawa T.","year":"2021","unstructured":"Hasegawa T.; Osaka M.; Miyamae Y.; Nishino K.; Isoda H.; Kawada K.; Neffati M.; Irie K.; Nagao M.; Two types of PPAR\u03b3 ligands identified in the extract of Artemisia campestris. Chemistry (Basel)  2021,3(2),647-657","journal-title":"Chemistry (Basel)"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.3390\/ijms19113447","volume":"19","author":"Cheng C.F.","year":"2018","unstructured":"Cheng C.F.; Ku H.C.; Lin H.; PGC-1\u03b1 as a pivotal factor in lipid and metabolic regulation. Int J Mol Sci  2018,19(11),3447","journal-title":"Int J Mol Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","volume":"40","author":"Corona J.C.","year":"2015","unstructured":"Corona J.C.; Duchen M.R.; PPAR\u03b3 and PGC-1\u03b1 as therapeutic targets in Parkinson\u2019s disease. Neurochem Res  2015,40(2),308-316","journal-title":"Neurochem Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12640-012-9342-7","volume":"23","author":"Carta A.R.","year":"2013","unstructured":"Carta A.R.; Pisanu A.; Modulating microglia activity with PPAR-\u03b3 agonists: a promising therapy for Parkinson\u2019s disease? Neurotox Res  2013,23(2),112-123","journal-title":"Neurotox Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/0971-6580.103660","volume":"19","author":"Chinnam P.","year":"2012","unstructured":"Chinnam P.; Mohsin M.; Shafee L.; Evaluation of acute toxicity of pioglitazone in mice. Toxicol Int  2012,19(3),250-254","journal-title":"Toxicol Int"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.3390\/ijms24043264","volume":"24","author":"P\u00e9rez-Segura I.","year":"2023","unstructured":"P\u00e9rez-Segura I.; Santiago-Balmaseda A.; Rodr\u00edguez-Hern\u00e1ndez L.D.; Morales-Mart\u00ednez A.; Mart\u00ednez-Becerril H.A.; Mart\u00ednez-G\u00f3mez P.A.; Delgado-Minjares K.M.; Salinas-Lara C.; Mart\u00ednez-D\u00e1vila I.A.; Guerra-Crespo M.; P\u00e9rez-Severiano F.; Soto-Rojas L.O.; PPARs and their neuroprotective effects in Parkinson\u2019s disease: A novel therapeutic approach in \u03b1-synucleinopathy? Int J Mol Sci  2023,24(4),3264","journal-title":"Int J Mol Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuro.2013.08.011","volume":"43","author":"Costa L.G.","year":"2014","unstructured":"Costa L.G.; de Laat R.; Dao K.; Pellacani C.; Cole T.B.; Furlong C.E.; Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection. Neurotoxicology  2014,43,3-9","journal-title":"Neurotoxicology"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.chmed.2022.11.005","volume":"15","author":"Gao J.","year":"2023","unstructured":"Gao J.; Zhang M.; Zu X.; Gu X.; Hao E.; Hou X.; Bai G.; Glucuronic acid metabolites of phenolic acids target AKT-PH domain to improve glucose metabolism. Chin Herb Med  2023,15(3),398-406","journal-title":"Chin Herb Med"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-022-10541-2","author":"Kumar H.B.","year":"2023","unstructured":"Kumar H.B.; Manandhar S.; Rathi E.; Kabekkodu S.P.; Mehta C.H.; Nayak U.Y.; Kini S.G.; Pai K.S.R.; Identification of potential Akt activators: A ligand and structure-based computational approach. Mol Divers  Epub ahead of print2023","journal-title":"Mol Divers"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.12659\/MSM.910764","volume":"24","author":"Jiang Y.","year":"2018","unstructured":"Jiang Y.; Liu J.; Zhou Z.; Liu K.; Liu C.; Diosmetin attenuates Akt signaling pathway by modulating nuclear factor kappa-light-chain-enhancer of Activated B cells (NF-\u03baB)\/inducible nitric oxide synthase (iNOS) in streptozotocin (STZ)-induced diabetic nephropathy Mice. Med Sci Monit  2018,24,7007-7014","journal-title":"Med Sci Monit"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/ptr.6596","volume":"34","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Wang Y.; Liu M.; Zhou B.; Yang G.; Diosmetin exhibits anti-proliferative and anti-inflammatory effects on TNF-\u03b1-stimulated human Rheumatoid arthritis fibroblast-like synoviocytes through regulating the Akt and NF-\u03baB signaling pathways. Phytother Res  2020,34(6),1310-1319","journal-title":"Phytother Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/j.1476-5381.2011.01817.x","volume":"166","author":"Ji R.","year":"2012","unstructured":"Ji R.; Sanchez C.M.; Chou C.L.; Chen X.B.; Woodward D.F.; Regan J.W.; Prostanoid EP  receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-\u03baB. Br J Pharmacol  2012,166(3),1033-1046","journal-title":"Br J Pharmacol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00207454.2024.2341916","volume":"24","author":"Srivastava R.","year":"2024","unstructured":"Srivastava R.; Choudhury P.K.; Dev S.K.; Rathore V.; Alpha-pine self-emulsifying nano formulation attenuates rotenone and trichloroethylene-induced dopaminergic loss. Int J Neurosci  2024,24,1-18","journal-title":"Int J Neurosci"},{"key":"ref=97","author":"Srivastava R.","year":"2023","unstructured":"Srivastava R.; Dilnashin H.; Kapoor D.; Sai A.; Heidarli E.; Singh S.P.; Jain V.; Role of animal models in Parkinson\u2019s disease (PD): What role they play in preclinical translational research. CNS Neurol Disord Drug Targets  2023","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/0109298665294109240323033601","volume":"31","author":"Varshney K.K.","year":"2024","unstructured":"Varshney K.K.; Gupta J.K.; Srivastava R.; Unveiling the molecular mechanism of diosmetin and its impact on multifaceted cellular signaling pathways. Protein Pept Lett  2024,31(4),275-289","journal-title":"Protein Pept Lett"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"e22902","DOI":"10.1002\/jbt.22902","volume":"35","author":"Srivastava R.","year":"2021","unstructured":"Srivastava R.; Choudhury P.K.; Dev S.K.; Rathore V.; Neuroprotective effect of \u03b1-pinene self-emulsifying nanoformulation against 6-OHDA induced neurotoxicity on human SH-SY5Y cells and its in vivo validation for anti-Parkinson\u2019s effect. J Biochem Mol Toxicol  2021,35(11),e22902","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.3390\/ijms23126853","volume":"23","author":"Abdollahi M.","year":"2022","unstructured":"Abdollahi M.; Fahnestock M.; Nurr1 is not an essential regulator of BDNF in mouse cortical neurons. Int J Mol Sci  2022,23(12),6853","journal-title":"Int J Mol Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1021\/acs.jmedchem.3c00415","volume":"66","author":"Vietor J.","year":"2023","unstructured":"Vietor J.; Gege C.; Stiller T.; Busch R.; Schallmayer E.; Kohlhof H.; H\u00f6fner G.; Pabel J.; Marschner J.A.; Merk D.; Development of a potent Nurr1 agonist tool for in vivo applications. J Med Chem  2023,66(9),6391-6402","journal-title":"J Med Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","volume":"27","author":"Courtney R.","year":"2016","unstructured":"Courtney R.; Landreth G.E.; LXR regulation of brain cholesterol: From development to disease. Trends Endocrinol Metab  2016,27(6),404-414","journal-title":"Trends Endocrinol Metab"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1039\/D1FO02579A","volume":"13","author":"Mei Z.","year":"2022","unstructured":"Mei Z.; Du L.; Liu X.; Chen X.; Tian H.; Deng Y.; Zhang W.; Diosmetin alleviated cerebral ischemia\/reperfusion injury in vivo and in vitro by inhibiting oxidative stress via the SIRT1\/Nrf2 signaling pathway. Food Funct  2022,13(1),198-212","journal-title":"Food Funct"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"13112","DOI":"10.1073\/pnas.1210833109","volume":"109","author":"Dai Y.","year":"2012","unstructured":"Dai Y.; Tan X.; Wu W.; Warner M.; Gustafsson J.\u00c5.; Liver X receptor \u03b2 protects dopaminergic neurons in a mouse model of Parkinson disease. Proc Natl Acad Sci USA  2012,109(32),13112-13117","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.3390\/molecules28124814","volume":"28","author":"Mateev E.","year":"2023","unstructured":"Mateev E.; Georgieva M.; Mateeva A.; Zlatkov A.; Ahmad S.; Raza K.; Azevedo V.; Barh D.; Structure-based design of novel MAO-B Inhibitors: A review. Molecules  2023,28(12),4814","journal-title":"Molecules"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1055\/s-0031-1296487","volume":"58","author":"Seif-El-Nasr M.","year":"2011","unstructured":"Seif-El-Nasr M.; Atia A.; Abdelsalam R.; Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant. Arzneimittel- forschung  2011,58(4),160-167","journal-title":"Arzneimittel- forschung"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.18632\/aging.204306","volume":"14","author":"Chiu Y.J.","year":"2022","unstructured":"Chiu Y.J.; Lin T.H.; Chang K.H.; Lin W.; Hsieh-Li H.M.; Su M.T.; Chen C.M.; Sun Y.C.; Lee-Chen G.J.; Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect A\u03b2-GFP SH-SY5Y cells against A\u03b2 toxicity. Aging  2022,14(18),7568-7586","journal-title":"Aging"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/234501","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234501\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/234501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T03:10:35Z","timestamp":1746069035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234501\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":107,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665333333240909104354","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}